Research > Institutional Review Board (IRB)

Institutional Review Board (IRB)

The LifeBridge Health Institutional Review Board (IRB) ensures that the rights and welfare of human subjects participating in research are adequately protected, the risks to subjects are outweighed by the potential benefits of the research, the selection of subjects is not coercive or biased, informed consent will be obtained and documented where appropriate, and there is scientific merit to the proposal.

Federal-Wide Assurance Number – FWA00003667
FWA Expiration Date is April 13, 2022

Please contact us if you need further assistance.

   Submission Deadlines

   
    Roster


STATEMENT OF COMPLIANCE


The LifeBridge Health, Inc. Institutional Review Board (LBH IRB) is duly constituted, has written procedures for initial and continuing review of clinical trials; prepares written minutes of convened meetings, and retains records pertaining to the review and approval process; all in compliance with requirements of FDA regulations 21 CFR Parts 50 and 56, HHS regulations 45 CFR 46, and International Conference on Harmonization (ICH) E6, and Good Clinical Practice (GCP), as applicable.

LBH is registered with OHRP/FDA; our IRB FWA is IRB00003667.

LBH also reviews in compliance with other applicable federal and state laws and regulations governing IRBs and research with human subjects. Where appropriate, LBH complies with additional regulations and guidelines (such as Ethical Conduct for Research Involving Humans) as required in specific research jurisdictions.

If you have questions or need further information, please do not hesitate to contact us.